News
Carfilzomib demonstrates efficacy as new frontline treatment regimen for...
Results from a study published online in Blood, the Journal of the American Society of Hematology (ASH), demonstrate that inclusion of carfilzomib, a novel...
News
Trastuzumab emtansine reduced the risk of cancer worsening or...
Roche announced that the Phase III EMILIA study of trastuzumab emtansine met its co-primary endpoint, of a significant improvement in the time patients with...
News
Boehringer Ingelheim expands development capacities with new technical centre
The research driven pharmaceutical company Boehringer Ingelheim is establishing a new 50 million-plus euro pilot plant facility for the production of newly developed active...
News
Bristol-Myers Squibb announces global collaboration with leading academic institutions
Bristol-Myers Squibb Company announced the formation of the International Immuno-Oncology Network (II-ON), a global collaboration between industry and academia that aims to further the...
News
Lundbeck’s Lu AE58054 meets primary endpoint
H. Lundbeck A/S today announced that Lu AE58054 has met its primary endpoint in a fixed dose, randomized, placebo-controlled clinical study in 278 patients...
News
Thioridazine, successfully kills cancer stem cells in the human
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic...
News
Innovative public-private collaboration launches to tackle antibiotic research
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.